SNN (Smith & Nephew) Tariff Resilience Score: 6/10 (As of Jul. 04, 2026)


SNN Smith & Nephew PLC SNN
84 GF Score
Price $30.25
GF Value $32.08
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew Tariff Resilience Score?

Smith & Nephew SNN +5.29% 84 Tariff Resilience Score is 6 as of Jul. 04, 2026. GuruFocus rates SNN with a GF Score™ of 84/100 and a GF Value™ of $32.08 (Fairly Valued). The stock has 3 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Smith & Nephew ranks better than 91.04% on this metric.

Smith & Nephew has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Smith & Nephew has Smith & Nephew PLC is a global medical device company with manufacturing in multiple countries. It faces moderate tariff risks due to its international sales and imports of raw materials. The company has some pricing power and can shift production to mitigate tariff impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Smith & Nephew might have Average Resilient.

Smith & Nephew  (NYSE:SNN) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Smith & Nephew Tariff Resilience Score Related Terms

SNN vs ABT, SYK, MDT: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Smith & Nephew's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Tariff Resilience Score falls into.


SNN
84GF Score
Smith & Nephew PLC SNN
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Smith & Nephew (SNN) has a Tariff Resilience Score of 6 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Smith & Nephew ranks #75 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Smith & Nephew's Tariff Resilience Score too high?
Smith & Nephew's current Tariff Resilience Score is 6. Based on the distribution chart, Smith & Nephew ranks #75 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Smith & Nephew has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Smith & Nephew's Tariff Resilience Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Smith & Nephew ranks #75 out of 837 companies for Tariff Resilience Score. This places Smith & Nephew in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Smith & Nephew's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smith & Nephew stock overvalued right now?
Based on GuruFocus' analysis, Smith & Nephew (SNN) is currently considered Fairly Valued. The stock's GF Value™ is $32.08, compared to a current price of $30.25 — trading 5.7% below its estimated fair value. The current Tariff Resilience Score is 6. Smith & Nephew's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Smith & Nephew (SNN), the current Tariff Resilience Score is 6 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Smith & Nephew (SNN) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of $30.25 is trading 5.7% below its estimated GF Value™ of $32.08. GuruFocus considers Smith & Nephew to be Fairly Valued.

Key valuation signals for SNN:

  • Tariff Resilience Score: 6
  • GF Value™: $32.08 vs. price of $30.25 (5.7% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the SNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
84GF Score

Get the complete analysis for SNN

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.25
Price
$32.08
GF Value